Brief: Lifetech Scientific IBS Coronary Scaffold Approved For Confirmatory Clinical Trials In China
26/08/2021 16:34
Aug 26 (Reuters) - LifeTech Scientific Corp 1302.HK :
* IBS CORONARY SCAFFOLD GOT IMPLIED PERMISSION FOR
CONDUCTING
CONFIRMATORY CLINICAL TRIALS IN CHINA
Source text for Eikon: ID:nHKSb4sPw1
Further company coverage: 1302.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeTech Scientific
See all newsBrief: Lifetech Scientific's Ics Elpis Admitted To Nmpa Special Examination On October 19, 2026
Brief: Lifetech Scientific Says Surechamtm Stent Graft Admitted To Nmpa Special Examination And Approval Procedure
Brief: Lifetech Scientific Expects Net Profit Attributable For Six Months Ended June 2026
Brief: Lifetech Scientific To Not Proceed With Major Deal
Brief: Lifetech Scientific To Buy 96.46% Of Starway Medical Technology